Breaking down the 55 new drug approvals of 2024
10 Jan 2025
13m
Fierce Life Sciences · Business
The Top Line
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
Episodes
Fierce 50 honorees look ahead: AI, rural health, antibiotic resistance, maternal care and more
20 Dec 2024
39m
Novo Nordisk’s chief scientific officer looks to the future of GLP-1s
13 Dec 2024
32m
What can we learn from 2024’s biotech IPOs?
06 Dec 2024
15m
Meet 2024’s fiercest women in life sciences
22 Nov 2024
12m
Misconduct and the future of neurodegenerative disease research
15 Nov 2024
15m
Dig into this year’s Fierce Biotech Graveyard, layoff numbers
08 Nov 2024
11m
Drug pricing and the 2024 presidential election
01 Nov 2024
16m
Discover Turbine’s way to build avatars true to patient biology [Sponsored]
28 Oct 2024
18m
The pulse of the medtech industry
25 Oct 2024
20m
Where are they now? Catching up with past Fierce 15 honorees
18 Oct 2024
32m
Revolutionizing gene therapy logistics with Cryoport's Elite solution [Sponsored]
14 Oct 2024
23m
A revival in neuro therapeutics
11 Oct 2024
40m
Breaking down BIOSECURE—Industry implications and what comes next
04 Oct 2024
20m
ESMO, WCLC lung cancer data spark hope—and debate
27 Sep 2024
23m
Recapping Digital Pharma East 2024
20 Sep 2024
8m
A closer look at the Fierce 50
13 Sep 2024
7m
A look at flu vaccine manufacturing and supply in the post-pandemic era
06 Sep 2024
17m
Driving flu vaccine uptake in the post pandemic era
29 Aug 2024
20m
The Crucial Role of HEK293 DNA Quantification in Biotherapeutics
26 Aug 2024
13m
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.